Table 1 MMR protein loss/intact expression detected at similar frequencies in curettage and hysterectomy series.

From: Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value

 

MutSα

MutLα

 

MSH6

MSH2

PMS2

MLH1

 

Intact (%)

Loss (%)

Intact (%)

Loss (%)

Intact (%)

Loss (%)

Intact (%)

Loss (%)

Curettage (n = 582)

550 (94.7)

31 (5.3)

567 (97.5)

14 (2.4)

450 (79.4)

117 (20.6)

491 (84.4)

91 (15.6)

Hysterectomy (n = 753)

709 (94.8)

39 (5.2)

730 (97.6)

18 (2.4)

566 (78.7)

153 (21.3)

609 (82.4)

130 (17.6)

  1. Missing information on curettage due to negative stromal straining of MSH6 and MSH2 for one patient and PMS2 for 15 patients. Data missing on hysterectomy due to negative stromal straining of MSH6 and MSH2 for five patients, PMS2 for 24 patients, MLH1 14 patients.